Skip to Content
Merck
CN

V900086

Thioacetamide

98%, Vetec™, reagent grade

Synonym(s):

Ethanethioamide

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
CH3CSNH2
CAS Number:
62-55-5
Molecular Weight:
75.13
UNSPSC Code:
12352100
PubChem Substance ID:
329829524
EC Number:
200-541-4
Beilstein/REAXYS Number:
506006
MDL number:
MFCD00008070
Assay:
98%

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Thioacetamide, Vetec™, reagent grade, 98%

InChI key

YUKQRDCYNOVPGJ-UHFFFAOYSA-N

InChI

1S/C2H5NS/c1-2(3)4/h1H3,(H2,3,4)

SMILES string

CC(N)=S

grade

reagent grade

product line

Vetec™

assay

98%

mp

108-112 °C (lit.)

functional group

amine

Looking for similar products? Visit Product Comparison Guide

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

pictograms

Health hazardExclamation mark
GHS08,GHS07

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
WXBF7781V
WXBF0621V
WXBB1985V
BCBJ5099V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Chiung-Kuei Huang et al.
Hepatology (Baltimore, Md.), 57(4), 1550-1563 (2012-11-15)
Transplantation of bone marrow mesenchymal stem cells (BM-MSCs) has been considered as an alternative therapy, replacing liver transplantation in clinical trials, to treat liver cirrhosis, an irreversible disease that may eventually lead to liver cancer development. However, low survival rate
Peng Zhan et al.
Archives of pharmacal research, 35(6), 975-986 (2012-08-09)
In continuation of our endeavor to develop new, potent, selective and less toxic antiviral agents, a novel series of 2-(2-amino/chloro-4-(2,4-dibromophenyl) thiazol-5-ylthio)acetamide derivatives was synthesized via an expeditious route and evaluated for their anti-HIV activities against wild-type virus and clinically relevant
Mladen I Yovchev et al.
Hepatology (Baltimore, Md.), 59(1), 284-295 (2013-07-11)
Considerable progress has been made in developing antifibrotic agents and other strategies to treat liver fibrosis; however, significant long-term restoration of functional liver mass has not yet been achieved. Therefore, we investigated whether transplanted hepatic stem/progenitor cells can effectively repopulate
Cun-hua Shao et al.
The Journal of surgical research, 186(1), 408-416 (2013-09-28)
Recent studies have demonstrated that bone marrow-derived mesenchymal stem cells (BM-MSCs) can potentially revert liver fibrosis, but it is not known if preparative hepatic irradiation (HIR) contributes to the therapeutic effect of transplanted BM-MSCs. In this study, we investigate the
Hong Ling et al.
PloS one, 8(1), e54499-e54499 (2013-01-26)
Considerable evidence has demonstrated that transforming growth factor β (TGF-β) plays a key role in hepatic fibrosis, the final common pathway for a variety of chronic liver diseases leading to liver insufficiency. Although a few studies have reported that blocking
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service